1-4 of 4
Emanuela Rosati
Close
Sort by
Journal Articles

NOTCH1 Aberrant Activation Is a Common Nonmutational Early Event in Chronic Lymphocytic Leukemia Hematopoietic Stem-Cells

Mauro Di Ianni, MD PhD, Stefano Baldoni, Beatrice Del Papa, Erica Dorillo, Elisa Albi, Raffaella Giancola, Patrizia Accorsi, Isabella Screpanti, Emanuela Rosati, Paolo Di Bartolomeo, MD, Franca Falzetti, MD, Paolo Sportoletti
Journal: Blood
Blood (2017) 130 (Supplement 1): 1725.
https://doi.org/10.1182/blood.V130.Suppl_1.1725.1725
Published: 2017
Journal Articles

Novel targets for endoplasmic reticulum stress-induced apoptosis in B-CLL

Emanuela Rosati, Rita Sabatini, Giuliana Rampino, Filomena De Falco, Mauro Di Ianni, Franca Falzetti, Katia Fettucciari, Andrea Bartoli, Isabella Screpanti, Pierfrancesco Marconi
Journal: Blood
Blood (2010) 116 (15): 2713–2723.
https://doi.org/10.1182/blood-2010-03-275628
Published: 2010
Journal Articles

Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells

Emanuela Rosati, Rita Sabatini, Giuliana Rampino, Antonio Tabilio, Mauro Di Ianni, Katia Fettucciari, Andrea Bartoli, Stefano Coaccioli, Isabella Screpanti, Pierfrancesco Marconi
Journal: Blood
Blood (2009) 113 (4): 856–865.
https://doi.org/10.1182/blood-2008-02-139725
Published: 2009
Journal Articles

Expression of type 1 (interferon gamma) and type 2 (interleukin-13, interleukin-5) cytokines at distinct stages of natural killer cell differentiation from progenitor cells

Matthew J. Loza, Loris Zamai, Livio Azzoni, Emanuela Rosati, Bice Perussia
Journal: Blood
Blood (2002) 99 (4): 1273–1281.
https://doi.org/10.1182/blood.V99.4.1273
Published: 2002